Canada markets close in 2 hours 23 minutes
  • S&P/TSX

    20,199.32
    -1.33 (-0.01%)
     
  • S&P 500

    4,251.93
    +5.49 (+0.13%)
     
  • DOW

    33,935.06
    -10.52 (-0.03%)
     
  • CAD/USD

    0.8134
    +0.0007 (+0.09%)
     
  • CRUDE OIL

    73.24
    +0.39 (+0.54%)
     
  • BTC-CAD

    41,327.39
    +1,070.39 (+2.66%)
     
  • CMC Crypto 200

    808.03
    -2.17 (-0.27%)
     
  • GOLD FUTURES

    1,783.50
    +6.10 (+0.34%)
     
  • RUSSELL 2000

    2,309.58
    +13.63 (+0.59%)
     
  • 10-Yr Bond

    1.4900
    +0.0180 (+1.22%)
     
  • NASDAQ

    14,292.04
    +38.78 (+0.27%)
     
  • VOLATILITY

    16.28
    -0.38 (-2.28%)
     
  • FTSE

    7,074.06
    -15.95 (-0.22%)
     
  • NIKKEI 225

    28,874.89
    -9.24 (-0.03%)
     
  • CAD/EUR

    0.6811
    +0.0007 (+0.10%)
     

NeuBase: Fiscal Q2 Earnings Snapshot

PITTSBURGH (AP) _ NeuBase Therapeutics, Inc. (NBSE) on Thursday reported a loss of $5.5 million in its fiscal second quarter.

On a per-share basis, the Pittsburgh-based company said it had a loss of 24 cents.

In the final minutes of trading on Thursday, the company's shares hit $4.64. A year ago, they were trading at $8.69.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBSE at https://www.zacks.com/ap/NBSE

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting